In ACD rats, the administration of ASP increased ferroportin expression, mobilized iron from the liver and spleen, increased serum iron levels, caused an elevation of serum EPO, and effectively relieved the anemia. The gene discussed is SLC40A1; the disease is granular corneal dystrophy type II.